Sign in

CIK 0001776111

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

MBX Biosciences, Inc.

Sign in to watch
Ticker
MBX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 317-989-3100
Business address
11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market buy Director bought 7,693 shares at $5.89 ($45,312)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market buy Director bought 190,672 shares at an average $10.60 ($2,020,756)
  6. 4 Open-market buy Director bought 190,672 shares at an average $10.60 ($2,020,756)
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Open-market buy President & CEO bought 50,000 shares at $10.69 ($534,500)
  10. 4 Open-market buy Director bought 500,000 shares at $16.00 ($8,000,000)
  11. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  12. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  13. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  14. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  15. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  16. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  17. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  18. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)
  19. 4 Open-market buy Director bought 750,000 shares at $16.00 ($12,000,000)
  20. 4 Open-market buy 10% owner bought 500,000 shares at $16.00 ($8,000,000)

Page 3 of 5 · 99 filings